Cargando…
尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究
OBJECTIVE: To compare the cytogenetic and molecular responses, outcomes and severe hematologic toxicity of nilotinib and imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase（CML-CP）. METHODS: Newly diagnosed CML-CP patients were consecutively recru...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342677/ https://www.ncbi.nlm.nih.gov/pubmed/32023729 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.005 |